Azithromycin
Azithromycin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
Genital chlamydial infections: 1 g as single dose All other indications: 500 mg daily for 3 daysTyphoid (unlicensed): 500 mg daily for 7 days PHARMACOKINETICS
Molecular weight                           :785 %Protein binding                           :12–52 %Excreted unchanged in urine     : 6–12 Volume of distribution (L/kg)       :31.1half-life – normal/ESRD (hrs)      :48–96/– DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Unknown dialysability. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntibacterials: possibly increased rifabutin concentration (increased risk of uveitis) – reduce dose of rifabutin)Anticoagulants: effect of coumarins may be enhancedAntidepressants: the manufacturer of reboxetine advises to avoid concomitant useAntihistamines: may inhibit the metabolism of mizolastine (risk of hazardous arrhythmias) – avoid concomitant useAntimalarials: avoid concomitant use with artemether/lumefantrineAntipsychotics: possibly increased quetiapine concentration – reduce quetiapine dose; possibly increased risk of ventricular arrhythmias with sertindole – avoid concomitant useAntivirals: concentration possibly increased by ritonavirCiclosporin: may inhibit the metabolism of ciclosporin (increased plasma ciclosporin levels)Ergot alkaloids: increased risk of ergotism – avoid concomitant useTheophylline: possibly increased theophylline concentration ADMINISTRATION
Reconstition
Powder for oral suspension to be reconstituted with water (200 mg/5 mL strength) Route
Oral Rate of Administration
–Comments
Administer as a once daily dose 1 hour before food or 2 hours after food.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home